Birch pollen allergy vaccine - HAL Allergy

Drug Profile

Birch pollen allergy vaccine - HAL Allergy

Alternative Names: SUBLIVAC FIX Birch; Sublivac Fix Birch

Latest Information Update: 05 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator HAL Allergy
  • Class Allergens; Antiallergics; Tree pollen allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic rhinitis; Allergic rhinoconjunctivitis

Most Recent Events

  • 30 Apr 2013 HAL Allergy completes a phase II trial in Allergic rhinitis and Allergic rhinoconjunctivitis in Czech Republic, Germany and Poland (NCT01639768)
  • 06 Nov 2012 HAL Allergy completes enrolment in its phase II trial for Allergic rhinitis and Allergic rhinoconjunctivitis in the Czech Republic, Poland and Germany (EudraCT2011-004550-25)
  • 31 Jul 2012 Phase-II clinical trials in Allergic rhinitis in Czech Republic (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top